This book was a surprise hit for me! I’ll be honest, I wasn’t expecting much, and only bought it because I was actually doing a Whole30 in January 2017 (it went great! I recommend it—I assume you’re thinking about it if you’re reading this review). We’ve been vegetarian for about 7 years, so eating and cooking so much meat, well, let’s just say I needed some help. The first thing I was impressed with? The recipes are very creative! They are easy to follow, don’t take a lot of time (I have a baby and a toddler and work from home), I particularly loved the slow-cooker recipes that make extra (beef roast, etc) that is then used for different recipes later in the week. Genius!
My husband and I are about to take a journey on the whole 30 and I was delighted when I came across your website. I have a couple of wonderings: Does all of your recipes strictly follow the whole 30 guidelines? I saw Coconut milk and honey in your chicken curry recipe…I really want to be able to use your recipes and follow the whole 30 the right way.
Trying to devise an ideal diet by studying contemporary hunter-gatherers is difficult because of the great disparities that exist; for example, the animal-derived calorie percentage ranges from 25% for the Gwi people of southern Africa to 99% for the Alaskan Nunamiut. Descendants of populations with different diets have different genetic adaptations to those diets, such as the ability to digest sugars from starchy foods. Modern hunter-gatherers tend to exercise considerably more than modern office workers, protecting them from heart disease and diabetes, though highly processed modern foods also contribute to diabetes when those populations move into cities.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”